BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10971315)

  • 1. Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.
    Silkstone VL; Tomlinson HS; Corlett SA; Chrystyn H
    Br J Clin Pharmacol; 2000 Sep; 50(3):281-4. PubMed ID: 10971315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization.
    Silkstone VL; Corlett SA; Chrystyn H
    Br J Clin Pharmacol; 2002 Aug; 54(2):115-9. PubMed ID: 12207629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser.
    Silkstone VL; Corlett SA; Chrystyn H
    Eur J Clin Pharmacol; 2002 Jan; 57(11):781-6. PubMed ID: 11868799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler.
    Hindle M; Peers EM; Parry-Billings M; Chrystyn H
    Br J Clin Pharmacol; 1997 Mar; 43(3):336-8. PubMed ID: 9088593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation.
    Chege JK; Chrystyn H
    Respir Med; 2000 Jan; 94(1):51-6. PubMed ID: 10714479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of salbutamol inhaled from a pressurized metered dose inhaler either alone or connected to a newly enhanced spacer design.
    Ammari WG; Oriquat GA; Sanders M
    Eur J Pharm Sci; 2020 Apr; 147():105304. PubMed ID: 32165316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.
    Hindle M; Chrystyn H
    Thorax; 1994 Jun; 49(6):549-53. PubMed ID: 8016791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.
    Hindle M; Newton DA; Chrystyn H
    Thorax; 1993 Jun; 48(6):607-10. PubMed ID: 8346489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices.
    Lipworth BJ; Clark DJ
    Br J Clin Pharmacol; 1998 Jul; 46(1):45-8. PubMed ID: 9690948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers.
    Du XL; Zhu Z; Fu Q; Li DK; Xu WB
    Acta Pharmacol Sin; 2002 Jul; 23(7):663-6. PubMed ID: 12100764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation.
    Mazhar SH; Ismail NE; Newton DA; Chrystyn H
    Br J Clin Pharmacol; 2008 Mar; 65(3):334-7. PubMed ID: 17922883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the relative bioavailability of salbutamol to the lung following inhalation.
    Hindle M; Chrystyn H
    Br J Clin Pharmacol; 1992 Oct; 34(4):311-5. PubMed ID: 1457264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man--no evidence of enantioselective lung metabolism.
    Ward JK; Dow J; Dallow N; Eynott P; Milleri S; Ventresca GP
    Br J Clin Pharmacol; 2000 Jan; 49(1):15-22. PubMed ID: 10606833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
    Moore A; Riddell K; Joshi S; Chan R; Mehta R
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion.
    Aswania OA; Corlett SA; Chrystyn H
    Br J Clin Pharmacol; 1999 Jun; 47(6):613-8. PubMed ID: 10383538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge.
    Tomlinson HS; Corlett SA; Allen MB; Chrystyn H
    Br J Clin Pharmacol; 2005 Dec; 60(6):605-10. PubMed ID: 16305584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salbutamol relative lung and systemic bioavailability of large and small spacers.
    Mazhar SH; Chrystyn H
    J Pharm Pharmacol; 2008 Dec; 60(12):1609-13. PubMed ID: 19000365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of bronchodilator therapy delivered by nebulization and metered-dose inhaler in mechanically ventilated patients.
    Marik P; Hogan J; Krikorian J
    Chest; 1999 Jun; 115(6):1653-7. PubMed ID: 10378564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Large Spacer Versus Nebulizer T-Piece in Single-Limb Noninvasive Ventilation.
    Harb HS; Elberry AA; Rabea H; Fathy M; Abdelrahim ME
    Respir Care; 2018 Nov; 63(11):1360-1369. PubMed ID: 30087193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumatic usage: some generic salbutamol metered dose inhalers can be used.
    Chege JK; Chrystyn H
    Thorax; 1994 Nov; 49(11):1162-3. PubMed ID: 7831635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.